ImpediMed News and Activities

ImpediMed is a company listed under the stock ticker IPD (AU).

View the org chart displaying its 19 main executives

Most searched biographies at ImpediMed

• Erik Anderson, Managing Director, Chief Executive Officer and Dire...
• Andrew Grant, Non-Executive Director
• Janelle Delaney, Non-Executive Director

Popular executive movements at ImpediMed

• Parmjot Bains, Managing Director and Chief Executive Officer, has left the company  (posted on April 8 2026).
• Erik Anderson, who was Director, is promoted to Managing Director, Chief Executive Officer and Director  (posted on April 8 2026).
• Erik Anderson has joined the company as Director  (posted on February 26 2026).

Create your alert
to follow the executive moves at ImpediMed.

ImpediMed has 1,235 competitors including Thermo Fisher Scientific (United States (USA)), Medtronic (Ireland) and Philips (Netherlands).

Popular M&A news in Medical Equipment

• Niowave has just announced a $70 Million fundraising (posted on June 2 2026).
• The new name of Edap Tms is FocalTherics. (posted on June 1 2026).
• FocalTherics is now listed under ticker FOCL. (posted on May 31 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Jacob Thaysen - Chief Executive Officer and Director at Illumina
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet

Learn more about the Medical Equipment industry

Press releases by ImpediMed

• Newsroom | ImpediMed - Part 5
• Newsroom | ImpediMed - Part 4
• Early Detection of Lymphedema and Value of Compression Garments After Breast Cancer Treatments with Dr. Steven Chen | ImpediMed
• New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival
• ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
• New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema
• Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema
• ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer
• ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
• ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
• View more press releases Close

Social media about ImpediMed

• ImpediMed on Wikipedia, Google News & Yahoo Finance
• ImpediMed on LinkedIn, X (Twitter) & YouTube